Literature DB >> 20671881

Clinical improvement induced by rituximab in two cases of type II mixed cryoglobulinaemia syndrome unresponsive to conventional treatments.

Sergio Cabibbo1, Agostino Antolino, Giovanni Garozzo, Giovanna O Manenti, Pietro Bonomo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20671881      PMCID： PMC2906198          DOI： 10.2450/2010.0093-09

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  6 in total

Review 1.  Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis.

Authors:  David Saadoun; Aurelien Delluc; Jean Charles Piette; Patrice Cacoub
Journal:  Curr Opin Rheumatol       Date:  2008-01       Impact factor: 5.006

Review 2.  Therapy of hepatitis C virus-associated glomerulonephritis: current approaches.

Authors:  Fabrizio Fabrizi; Giovanna Lunghi; Piergiorgio Messa; Paul Martin
Journal:  J Nephrol       Date:  2008 Nov-Dec       Impact factor: 3.902

Review 3.  Should rituximab be the rescue therapy for refractory mixed cryoglobulinemia associated with hepatitis C?

Authors:  Muhammad S Ahmed; Christopher F Wong
Journal:  J Nephrol       Date:  2007 May-Jun       Impact factor: 3.902

4.  Efficacy and safety of rituximab in type II mixed cryoglobulinemia.

Authors:  Francesco Zaja; Salvatore De Vita; Cesare Mazzaro; Stefania Sacco; Daniela Damiani; Ginevra De Marchi; Angela Michelutti; Michele Baccarani; Renato Fanin; Gianfranco Ferraccioli
Journal:  Blood       Date:  2003-01-30       Impact factor: 22.113

Review 5.  Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand?

Authors:  P Cacoub; A Delluc; D Saadoun; D A Landau; D Sene
Journal:  Ann Rheum Dis       Date:  2007-07-20       Impact factor: 19.103

6.  Rituximab in mixed cryoglobulinemia: increased experience and perspectives.

Authors:  Salvatore De Vita; Luca Quartuccio; Martina Fabris
Journal:  Dig Liver Dis       Date:  2007-09       Impact factor: 4.088
  6 in total
  1 in total

Review 1.  Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC).

Authors:  Luca Quartuccio; Alessandra Bortoluzzi; Carlo Alberto Scirè; Antonio Marangoni; Giulia Del Frate; Elena Treppo; Laura Castelnovo; Francesco Saccardo; Roberta Zani; Marco Candela; Paolo Fraticelli; Cesare Mazzaro; Piero Renoldi; Patrizia Scaini; Davide Antonio Filippini; Marcella Visentini; Salvatore Scarpato; Dilia Giuggioli; Maria Teresa Mascia; Marco Sebastiani; Anna Linda Zignego; Gianfranco Lauletta; Massimo Fiorilli; Milvia Casato; Clodoveo Ferri; Maurizio Pietrogrande; Pietro Enrico Pioltelli; Salvatore De Vita; Giuseppe Monti; Massimo Galli
Journal:  Clin Rheumatol       Date:  2022-09-28       Impact factor: 3.650
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.